3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Carcinoma, Non-Small-Cell Lung
130
Brain Neoplasms
115
Prostatic Neoplasms
101
Neoplasm Metastasis
83
Lung Neoplasms
72
Carcinoma, Hepatocellular
71
Pancreatic Neoplasms
67
Breast Neoplasms
48
Melanoma
44
Carcinoma, Renal Cell
36
Neoplasms
33
Colorectal Neoplasms
26
Squamous Cell Carcinoma of Head and Neck
25
Glioblastoma
24
Liver Neoplasms
20
Head and Neck Neoplasms
16
Small Cell Lung Carcinoma
15
Sarcoma
13
Glioma
12
Kidney Neoplasms
11
Urinary Bladder Neoplasms
9
Recurrence
9
Gliosarcoma
8
Ovarian Neoplasms
7
Adenocarcinoma of Lung
7
Adenocarcinoma
7
Prostate Cancer Metastatic
6
Cholangiocarcinoma
6
Central Nervous System Neoplasms
6
Uveal Melanoma
5
Interventions
lanreotide
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Temozolomide
1
Solutions
1
Radiosurgery
1
Microarray Analysis
1
Injections
1
Early Intervention, Educational
1
Diet, Mediterranean
1
Diet, Ketogenic
1
DNA Methylation
1
Complementary Therapies
1
Biological Therapy
1
90Y-octreotide, DOTA-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Growth Hormone-Secreting Pituitary Adenoma
×
Radiosurgery
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled